Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Pfizer R&D head exits for AstraZeneca

May 27, 2010 Research and Development AstraZeneca, Pfizer, appointment, research and development

One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …
News

Sanofi signs biomedical collaboration with MIT

May 27, 2010 Research and Development MIT, Sanofi-Aventis, academia, biomedical

Sanofi-Aventis has formed a strategic alliance with the Centre for Biodmedical Innovation  at the Massachusetts Institute of Technology. The alliance, …
News

Roche forms translational medicine research hub

May 26, 2010 Research and Development Roche, Switzerland, academic research, translational

Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …
News
Abbott sign

Abbott starts head-to-head MS trial

May 25, 2010 Research and Development, Sales and Marketing Abbott, Avonex, Biogen, Gilena, daclizumab

Abbott has started enrolment for a phase III trial of daclizumab, a once-monthly injection for relapsing-remitting multiple sclerosis that it …
News

Kaiser Permanente unit joins Quintiles ‘Prime Site’ network

May 25, 2010 Research and Development CRO, Kaiser Permanente, Quintiles

A unit of US health maintenance organisation Kaiser Permanente has become the fourth in Quintiles’ network of ‘Prime Sites’ – …
News

Lucentis boosted by diabetic vision study

May 24, 2010 Research and Development, Sales and Marketing AMD, DME, Lucentis, Novartis

A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …
News

Boehringer selects lead candidate for Alzheimer’s

May 24, 2010 Research and Development Ablynx, Boehringer

Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …
News

Eisai opens $100m parenterals plant in North Carolina

May 24, 2010 Manufacturing and Production, Research and Development Aricept, Eisai, eribulin, parenterals

Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …
News

First artificial life created

May 24, 2010 Research and Development Cell biology, Venter, cell, genome

Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …
News

Silence Therapeutics promotes Jorg Kaufmann

May 21, 2010 Research and Development Silence Therapeutics, appointment, research and development, rnai

Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …
Appointment

Antisoma stages comeback with promising cancer drugs

May 20, 2010 Research and Development AML, Antisoma, chemotherapy, leukaemia

UK biotech Antisoma is looking to put previous late-stage trial failures behind it by focusing on two new cancer drugs. …
News

Working Life: Dr John Sinden

May 19, 2010 Research and Development ReNeuron, Working Life, career

 ReNeuron’s chief scientific officer discusses his career to date. How did you find your way into your current role?
Feature

Chiltern Announces new Offices and Expansion Plans in Asia Pacific

May 19, 2010 Research and Development

This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company …
News
Press release

UCB’s Roch Doliveux joins Innovative Medicines Initiative board

May 19, 2010 Research and Development UCB, appointment, research and development

UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …
Appointment
FerringSteveHowson

Steve Howson to lead Ferring UK

May 18, 2010 Research and Development, Sales and Marketing Ferring, appointment, research and development, sales and marketing

Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025